Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
about
Topiramate for acute affective episodes in bipolar disorderAdd-on topiramate reduces weight in overweight patients with affective disorders: a clinical case seriesPsychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver diseaseEffects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytesWeight gain, obesity, and psychotropic prescribing.Poor response to treatment: beyond medication.Metabolic disturbances independent of body mass in patients with schizophrenia taking atypical antipsychoticsSchizophrenia and weight management: a systematic review of interventions to control weight.Weight gain mitigation with topiramate in mood disorders.Psychiatric medication-induced obesity: a review.Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial.Biological aging alters circadian mechanisms in murine adipose tissue depotsTopiramate and type 2 diabetes: an old wine in a new bottle.Psychopharmacology of topiramate: from epilepsy to bipolar disorder.Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.Drug-induced hyperphagia: what can we learn from psychiatric medications?Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial.Fat circadian biologyLithium side effects and toxicity: prevalence and management strategies.Obesity and psychotropics.Combination phentermine/topiramate for obesity treatment in primary care: a review.Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.Zonisamide decreases ethanol intake in rats and mice.Differences in body mass index according to fat mass- and obesity-associated (FTO) genotype in Mexican patients with bipolar disorder.Metformin for Lithium-induced Weight Gain: A Case Report.Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia.[Efficacy of behavioural lifestyle interventions for weight management of psychiatric patients].Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: findings of the Research on Asia Psychotropic Prescription (REAP) studies.Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice.Open-label adjunctive topiramate in the treatment of unstable bipolar disorder.Factors influencing weight gain in an Asian population of psychiatric inpatients: a retrospective study in Taiwan.A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.White Matter Hyperintensities on Brain Magnetic Resonance Imaging in People with Epilepsy: A Hospital-Based Study.Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial.Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study
P2860
Q24244960-3940E9EB-7768-4ACE-BB81-4F238599A434Q24793223-F293A62C-515C-43DE-AE15-ED7DCFA884E8Q27012600-338325F7-9739-408D-9958-ED00CC6E62D9Q33319636-F2A1B900-E1D2-4EFC-A3BB-A0F4D35895B1Q34557537-61BF248D-4DFA-4171-838F-F2C7C348D2EBQ35236765-C05D1C37-58FF-4A40-8021-562E5DF40B68Q35330607-87970ACF-AF4D-4B7A-9131-FC45CA395CB0Q35553266-4E543EA9-016E-4082-B727-0116FCD075ACQ35708565-3E0936A9-97D8-45F0-B444-9F30E428BAF6Q35746806-8A563CBF-78FF-4453-90E9-985554866D76Q36197756-ECDEAA62-02AF-4A15-B84B-D7DC8833C7ADQ36199036-3FDFD427-8B13-4FF3-9E11-7003A6C85F7CQ36564507-F7E5CAE9-8FB2-4CDD-BCD7-31A9E46D3911Q36795172-E8E75338-667A-4FFC-8A01-822F509BF889Q37030881-0ED7BCA3-662D-4A2C-9A4A-0311A1150106Q37166152-F9A2B048-282A-4B54-B708-CE30F51A60D2Q37171035-D33E4F12-33D3-4B6F-BCA1-FAA4C7DC6260Q37254782-45069C55-26A2-46BF-83DA-2969C20AB5D9Q37366007-A6522201-BA5C-43C1-8AB7-E97BE213F2E6Q37422118-B8975EC5-22C4-4131-B65E-2A0673569E69Q37511785-8449434C-C2EA-4F9A-BFB5-D24DDCBCE4C2Q37954390-C8734786-A5F5-45A2-90F8-6AB079CC7D53Q38200830-74B0CF22-7EAD-47DF-AD19-CC33C19CF490Q38677949-C87E7979-1EC6-4ED1-B147-93C50886C346Q40469992-24158FF4-0571-4E20-8C3B-EB936E90B9AEQ41154695-6A05B872-156E-441B-AE05-EC60CAA85DCEQ41771822-31AB2247-9F6C-41EC-8A78-1D5EA6E4B45BQ44269727-82978000-6C02-45B0-BA06-FB57C3D627A5Q45209540-702E1081-9C5C-4116-B95C-B681227DFE98Q45732990-EF01C86D-ECA8-4258-AC6B-AE0A6DB3144AQ46545824-0EC6C10B-731B-46D2-A7ED-9762C413E5F4Q46639807-2E2829AB-8A61-45A1-9B2B-5ABC8BC0BDF8Q47222980-8F0CC396-2A98-4868-87A7-79D7DDD1325BQ47285127-1EBAAA2A-214A-4569-BA03-9D632863F653Q47947938-4F4D4BF5-84F1-4707-B99F-4625B30870EEQ48007999-825B78E7-51D9-40A2-962E-810D01E3E426Q50654258-39B8EB1F-0B73-4C00-8210-FFFFFD3C3CAEQ50773348-3AD0FAAD-FA51-4D97-8B32-20209990F286Q57260389-0C5AC35F-2235-4DB5-868E-A3EF1F8C9F42
P2860
Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Changes in body weight and bod ...... l, nonrandomized chart review.
@ast
Changes in body weight and bod ...... l, nonrandomized chart review.
@en
type
label
Changes in body weight and bod ...... l, nonrandomized chart review.
@ast
Changes in body weight and bod ...... l, nonrandomized chart review.
@en
prefLabel
Changes in body weight and bod ...... l, nonrandomized chart review.
@ast
Changes in body weight and bod ...... l, nonrandomized chart review.
@en
P2093
P1476
Changes in body weight and bod ...... l, nonrandomized chart review.
@en
P2093
H Parepally
Jaspreet S Brar
Joseph Levine
K N Roy Chengappa
L Chalasani
Patricia Houck
P304
P356
10.1016/S0149-2918(02)80061-3
P577
2002-10-01T00:00:00Z